Effects of different exercise programs and minimal detectable changes in hemoglobin A1c in patients with type 2 diabetes

被引:10
作者
de lade, Carlos Gabriel [1 ]
Bouzas Marins, Joao Carlos [1 ]
Lima, Luciana Moreira [1 ,2 ]
de Carvalho, Cristiane Junqueira [1 ,2 ]
Teixeira, Robson Bonoto [1 ]
Albuquerque, Maicon Rodrigues [1 ]
Reis, Janice Sepulveda [3 ]
dos Santos Amorim, Paulo Roberto [1 ]
机构
[1] Univ Fed Vicosa, Phys Educ Dept, Av PH Rolfs S-N,Campus Univ, BR-36570900 Vicosa, MG, Brazil
[2] Univ Fed Vicosa, Med & Nursing Dept, Vicosa, MG, Brazil
[3] Santa Casa Belo Horizonte, Rua Domingos Vieira 300-504, BR-30150240 Belo Horizonte, MG, Brazil
关键词
Diabetes mellitus; Hemoglobin A1c; Strength training; Aerobic training; Minimum detectable change; GLYCEMIC CONTROL; RESISTANCE; PREVALENCE; MELLITUS; TESTS;
D O I
10.1186/s13098-016-0123-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The incidence of diabetes mellitus is increasing worldwide, resulting in a global epidemic. The most common type, the type 2 diabetes mellitus, constitutes of 90-95 % of the cases and is characterized by the action of and/or impaired insulin secretion. Regular exercise is a recommended strategy in several studies and guidelines for type 2 diabetes control and complications associated with it. Therefore, we evaluated and compared the effects of aerobic and strength exercise programs on the glycemic control in patients with type 2 diabetes. Methods: The selected patients were divided into groups which performed moderate strength training (ST) and aerobic training (AT). The study lasted 20 weeks and was divided into two 10 week phases with anthropometric (body mass index, waist, abdomen and hips circumferences, waist/hip ratio) and biochemical (glycemic and lipid profile) assessments at baseline, 10 weeks and 20 weeks. For intra and inter analyses a mixed ANOVA model was used. Individual changes were calculated using the minimum detectable change, based on a 90 % confidence interval. Results: Eleven patients (five men and six women) completed the 20 weeks of training; five from the ST group and six from the AT. No significant changes were observed in any anthropometric variable in either group. Statistically significant differences were found in mean hemoglobin A1c in both groups between baseline (AT: 8.6 +/- 2.5; ST: 9.2 +/- 1.9) and 10 weeks (AT: 7.2 +/- 1.7; ST: 7.9 +/- 1.2) (p = 0.03), and baseline (AT: 8.6 +/- 2.5; ST: 9.2 +/- 1.9) and 20 weeks (AT: 7.5 +/- 1.7; ST: 7.4 +/- 0.9) (p = 0.01). For the minimal detectable changes, 40 % of the ST and 33 % of AT achieved these changes for hemoglobin A1c. Conclusion: Both aerobic and strength exercises can help the metabolic control in patients with type 2 diabetes, even without significant changes in anthropometry over the 20 weeks of training. However, this period was sufficient to cause changes in hemoglobin A1c values and the estimated average glucose, which are important parameters in controlling diabetes, thus signaling an important consequence of adhering to an exercise routine for type 2 diabetic patients.
引用
收藏
页数:9
相关论文
共 50 条
[31]   To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes? [J].
Smetana, Gerald W. ;
Nathan, David M. ;
Dugdale, David C. ;
Burns, Risa B. .
ANNALS OF INTERNAL MEDICINE, 2019, 171 (07) :505-+
[32]   Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin [J].
Liu, Hao ;
Hu, Yun ;
Li, Feng-fei ;
Liu, Bing-li ;
Su, Xiao-fei ;
Ma, Jian-hua .
DIABETES THERAPY, 2016, 7 (04) :743-753
[33]   Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither? [J].
Giugliano, Dario ;
Maiorino, Maria Ida ;
Bellastella, Giuseppe ;
Petrizzo, Michela ;
Ceriello, Antonio ;
Genovese, Stefano ;
Esposito, Katherine .
ENDOCRINE, 2015, 50 (01) :56-60
[34]   Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial [J].
Tian, Jingyan ;
Ohkuma, Toshiaki ;
Cooper, Mark ;
Harrap, Stephen ;
Mancia, Giuseppe ;
Poulter, Neil ;
Wang, Ji-Guang ;
Zoungas, Sophia ;
Woodward, Mark ;
Chalmers, John .
DIABETES CARE, 2020, 43 (06) :1293-1299
[35]   Predictors of medication regimen complexity and its impact on hemoglobin a1c in type 2 diabetes patients: a retrospective analysis in ambulatory care in Makkah City [J].
Khayyat, Sarah M. ;
Ali, Ruba S. Azfr ;
Alrammaal, Hanadi H. ;
Khayyat, Salwa M. S. ;
Alqurashi, Wafaa A. ;
Alsaedi, Reemaz ;
Alotaibi, Wejdan ;
Alahmadi, Aseel .
ANNALS OF SAUDI MEDICINE, 2024, 44 (05) :296-305
[36]   Target for Glycemic Control in Type 2 Diabetic Patients on Hemodialysis: Effects of Anemia and Erythropoietin Injection on Hemoglobin A1c [J].
Uzu, Takashi ;
Hatta, Tsuguru ;
Deji, Naoko ;
Izumiya, Tamani ;
Ueda, Hisami ;
Miyazawa, Itsuko ;
Kanasaki, Masami ;
Isshiki, Keiji ;
Nishio, Toshiji ;
Arimura, Tetsuro .
THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (02) :89-94
[37]   Relationship between glycosylated hemoglobin A1c and coronary flow reserve in patients with Type 2 diabetes mellitus [J].
Huang, Runqing ;
Abdelmoneim, Sahar S. ;
Nhola, Lara F. ;
Basu, Rita ;
Basu, Ananda ;
Mulvagh, Sharon L. .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (04) :445-453
[38]   Associations of Four Community Factors With Longitudinal Change in Hemoglobin A1c Levels in Patients With Type 2 Diabetes [J].
Hirsch, Annemarie G. ;
Durden, T. Elizabeth ;
Nordberg, Cara ;
Berger, Andrea ;
Schwartz, Brian S. .
DIABETES CARE, 2018, 41 (03) :461-468
[39]   Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes [J].
Huang, Lingning ;
Yang, Liyong ;
Shen, Ximei ;
Yan, Sunjie .
METABOLIC BRAIN DISEASE, 2016, 31 (02) :347-353
[40]   Hemoglobin A1c and blood pressure in type2 diabetic patients [J].
Aldossary, Ahmed Talib Yassen ;
Mohammed, Abdullah Ali ;
Nawfal, Ahmed Jasim ;
Alqatab, Alaa Hashim .
EGYPTIAN JOURNAL OF CHEMISTRY, 2021, 64 (11) :6285-6291